TORONTO, ON – A new program that provides nascent software companies with start-up funds, work space, mentoring and business strategy support, was launched today by the University of Toronto and commercialization partner MaRS Innovation, with support from the MaRS Discovery District.
TechVibes has a profile page for UTEST and covered CoursePeer as part of their students start-ups series.
The new program, called University of Toronto Early Stage Technology (UTEST), is part of a growing ecosystem of incubators and commercialization support services at U ...
MaRS Innovation's Vice-President of Business Development and Physical Sciences Joel Liederman, has published an article in the Financial Post about strategies to mitigate risk within the innovation space.
The article, titled "Innovation Success Means Mitigating Risk," is featured in the newspaper's Productive Conversations section. (more…)
Encycle Therapeutics, a MaRS Innovation spin-off company, was included in BioCentury's companies to watch within the macrocycle chemistry space.
The reference came in Chris Cain's article, "Maturing macrocycle chemistry drives explosion of biotech newcos, biopharma deals." (more…)
MISSISSAUGA, Ontario, September 18, 2012 – CML HealthCare Inc. (TSX: CLC) (the “Company” or “CML”) and MaRS Innovation (MI), a Centre of Excellence for Commercialization and Research, have entered into a strategic partnership to commercialize early-stage technologies that present innovative methods in medical diagnostics.
This story was covered in the Globe and Mail, Canadian Business, 680 News, Reuters, Sympatico.ca, the Huffington Post Canada, Technology Trasnfer Tactics, and the Winnipeg Free Press, among others. It was distributed via Yahoo! Finance, Healthcare Global.com, marketwire ...
Hossein Rahnama, CEO of Flybits, a MaRS Innovation spin-off company, appeared on CBC's Lang and O'Leary Exchange on August 24, 2012.
Watch Rahnama's interview on CBC's Media Player. The interview begins at the 13:40 mark and runs to 19:30.
Rahnama, who is also a professor at Ryerson University and and research director at Ryerson's Digital Media Zone, was recently named to the MIT Technology Review’s prestigious 35 Inventors Under 35 list for 2012 along with fellow MaRS Innovation inventor Joyce Poon.
He describes his ...
Professors Joyce Poon and Hossein Rahnama, who each have inventions within MaRS Innovation's portfolio of spin-off companies and licenseable technologies, have been named to the MIT Technology Review's prestigious 35 Inventors Under 35 list for 2012.
Poon, an assistant professor of electrical and computer engineering at the University of Toronto, was recognized for, according to MIT's Technology Review, "creating new optical modulators with microscopic loop-the-loops through which light can shuttle data between servers and even from chip to chip within a single ...
Andrew Sinclair, CEO of OtoSim Inc. and a senior director at MaRS Innovation, describes some of the unexpected twists and turns OtoSim has weathered in bringing their product to market in a post on the mark in a post featured on the MaRS Discovery District's blog today.
OtoSim, a MaRS Innovation spin-off company, makes an otoscopy training and simulation system for ear examination, know as the OtoSim™ device, which has been shown to improve medical professionals’ accuracy when diagnosing ear pathologies by 44 ...
Raphael Hofstein, president and CEO of MaRS Innovation, was interviewed by Huffington Post Canada business reporter Rachel Mendleson for an article about Canada's innovation gap and the shortage of Canadian venture capital:
One of the best ways to [raise venture capital], said Raphael Hofstein, President and CEO of Toronto-based MaRS Innovation, is to increase government investment, a lesson he learned while helping to create a life sciences early-stage fund in Israel several years ago.
“Everybody told us — institutions, industry — that they ...
Joel Liederman, MaRS Innovation’s vice-president of Business Development and Physical Sciences, was quoted in a National Post article, published August 13, probing whether Canadian research is passing the commercialization test.
Here's an excerpt:
While academics have often been accused of being disconnected from the real world and consuming themselves with the theoretical, it’s hard to imagine they would be able to get away with squandering funding dollars on things that make them go hmmm, particularly in light of the hyper focus on fiscal ...
Xagenic, a MaRS Innovation spin-off company, was featured in the most recent issue of BioCentury.
Here's an excerpt (the article only available to BioCentury subscribers):
PCR-based diagnosis of infections can delay treatment decisions by days or hours because the method relies on technical expertise and equipment not available in most point-of-care settings. Xagenic Inc.'s chip-based arrays use a non-PCR, electrochemical approach to diagnose bacterial infections at the point of care in 20 minutes with PCR-like accuracy.
Xagenic's core technology is a silicon chip containing ...